Notch-1 Regulates Cell Death Independently of Differentiation in Murine Erythroleukemia Cells Through Multiple Apoptosis and Cell Cycle Pathways

Journal of Cellular Physiology

Volumn 199, Issue 3, 2004, Pages 418-433

  Jang, Mei Shiang ^a   Miao, Haixi ^a   Carlesso, Nadia ^b   Shelly, Leslie ^c   Zlobin, Andrei ^a   Darack, Nicole ^d   Qin, Jian Zhong ^a,e   Nickoloff, Brian J ^a,e   Miele, Lucio ^d  

^a LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CALCIUM ION; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; NOTCH RECEPTOR; NOTCH1 RECEPTOR; PEPTIDE; PROTEIN; PROTEIN BCL XL; PROTEIN P21; PROTEIN P27; RETINOBLASTOMA PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CELL CYCLE; CELL DEATH; CELL DIFFERENTIATION; CELL FATE; CONTROLLED STUDY; DNA BINDING; DOSE TIME EFFECT RELATION; DOWN REGULATION; DRUG MECHANISM; DRUG TARGETING; ERYTHROLEUKEMIA CELL; GENE; GENE EXPRESSION; HEMATOPOIETIC SYSTEM TUMOR; MOUSE; NONHUMAN; NOTCH1 GENE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SOLID TUMOR;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; BLOTTING, WESTERN; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; DOWN-REGULATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, NOTCH1; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

MURINAE;

EID: 2342471446     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10467     Document Type: Article

References (101)

1. Artavanis-Tsakonas S, Rand MD, Lake RJ. 1999. Notch signaling: Cell fate control and signal integration in development. Science 284:770-776.
2. Asada M, Yamada T, Ichijo H, Delia D, Miyazono K, Fukumuro K, Mizutani S. 1999. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J 18:1223-1234.
3. Baonza A, Garcia-Bellido A. 2000. Notch signaling directly controls cell proliferation in the Drosophila wing disc. Proc Natl Acad Sci USA 97:2609-2614.
4. Bellavia D, Campese AF, Alesse E, Vacca A, Felli MP, Balestri A, Stoppacciaro A, Tiveron C, Tatangelo L, Giovarelli M, Gaetano C, Ruco L, Hoffman ES, Hayday AC, Lendahl U, Frati L, Gulino A, Screpanti I. 2000. Constitutive activation of NF-kappaB and T-cell Ieukemia/lymphoma in Notch3 transgenic mice. EMBO J 19:3337-3348.
5. Bocchetta M, Miele L, Pass HI, Carbone M. 2003. Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells. Oncogene 22:81-89.
6. Callahan R, Raafat A. 2001. Notch signaling in mammary gland tumorigenesis. J Mammary Gland Biol Neoplasia 6:23-36.
7. Capobianco AJ, Zagouras P, Blaumueller CM, Artavanis-Tsakonas S, Bishop JM. 1997. Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2. Mol Cell Biol 17:6265-6273.
8. Carlesso N, Aster JC, Sklar J, Scadden DT. 1999. Notch1-induced delay of human hematopoietic progenitor cell differentiation is associated with altered cell cycle kinetics. Blood 93:838-848.
9. Cereseto A, Tsai S. 2000. Jagged2 induces cell cycling in confluent fibroblasts susceptible to density-dependent inhibition of cell division. J Cell Physiol 185:425-431.
10. Chao DT, Korsmeyer SJ. 1998. BCL-2 family: Regulators of cell death. Annu Rev Immunol 16:395-419.
11. Chaturvedi MM, Kumar A, Darnay BG, Chainy GB, Agarwal S, Aggarwal BB. 1997. Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappaB activation, IkappaBalpha phosphorylation, and degradation. J Biol Chem 272:30129-30134.
12. Chauhan D, Hideshima T, Treon S, Teoh G, Raje N, Yoshihimito S, Tai YT, Li W, Fan J, DeCaprio J, Anderson KC. 1999. Functional interaction between retinoblastoma protein and stress-activated protein kinase in multiple myeloma cells. Cancer Res 59:1192-1195.
13. Chen YR, Tan TH. 2000. The c-Jun N-terminal kinase pathway and apoptotic signaling (review). Int J Oncol 16:651-662.
14. Cheng P, Zlobin A, Volgina V, Gottipati S, Osborne B, Simel EJ, Miele L, Gabrilovich DI. 2001. Notch-1 regulates NF-kappaB activity in hemopoietic progenitor cells. J Immunol 167:4458-4467.
15. Daniel B, Rangarajan A, Mukherjee G, Vallikad E, Krishna S. 1997. The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. J Gen Virol 78:1095-1101.
16. Davis RJ. 1999. Signal transduction by the c-Jun N-terminal kinase. Biochem Soc Symp 64:1-12.
17. Deftos ML, He Y-W, Ojata EW, Bevan MJ. 1998. Correlating Notch signaling with thymocyte maturation. Immunity 9:777-786.
18. Deftos ML, Huang E, Ojala EW, Forbush KA, Bevan MJ. 2000. Notch1 signaling promotes the maturation of CD4 and CD8 SP thymocytes. Immunity 13:73-84.
19. Dievart A, Beaulieu N, Jolicoeur P. 1999. Involvement of Notch1 in the development of mouse mammary tumors. Oncogene 18:5973-5981.
20. Dou QP, An B. 1998. RB and apoptotic cell death. Front Biosci 3:d419-d430.
21. Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, Smith SD, Sklar J. 1991. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66:649-661.
22. Endo Y, Osumi N, Wakamatsu Y. 2003. Deltex/Dtx mediates NOTCH signaling in regulation of Bmp4 expression in cranial neural crest formation during avian development. Dev Growth Differ 45:241-248.
23. Fitzgerald K, Harrington A, Leder P. 2000. Ras pathway signals are required for notch-mediated oncogenesis. Oncogene 19:4191-4198.
24. Fukuda K, Yamamoto M. 1999. Acquisition of resistance to apoptosis and necrosis by Bcl-xL over-expression in rat hepatoma McA-RH8994 cells. J Gastroenterol Hepatol 14:682-690.
25. Garces C, Ruiz-Hidalgo MJ, Font de Mora J, Park C, Miele L, Goldstein J, Bonvini E, Porras A, Laborda J. 1997. Notch-1 controls the expression of fatty acid-activated transcription factors and is required for adipogenesis. J Biol Chem 272:29729-29734.
26. Gervais JL, Seth P, Zhang H. 1998. Cleavage of CDK inhibitor p21(Cip1/Waf1) by caspases is an early event during DNA damage-induced apoptosis. J Biol Chem 273:19207-19212.
27. Gillo B, Ma YS, Marks AR. 1993. Calcium influx in induced differentiation of murine erythroleukemia cells. Blood 81:783-792.
28. Glasgow JN, Qiu J, Rassin D, Grafe M, Wood T, Perez-Pol JR. 2001. Transcriptional regulation of the BCL-X gene by NF-kappaB is an element of hypoxic responses in the rat brain. Neurochem Res 26: 647-659.
29. Greenwald I. 1998. LIN-12/Notch signaling: Lessons from worms and flies. Genes Dev 12:1751-1762.
30. Guan E, Wang J, Laborda J, Norcross M, Baeuerle PA, Hoffman T. 1996. T cell leukemia-associated human Notch/translocation-associated Notch homologue has I kappa B-like activity and physically interacts with nuclear factor-kappa B proteins in T cells. J Exp Med 183:2025-2032.
31. Harbour JW, Dean DC. 2000. Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol 2:E65-E67.
32. Haupt Y. 1995. p53-mediated apoptosis in HeLa cells can be overcome by excess pRB. Oncogene 10:1563-1571.
33. Herwig S, Strauss M. 1997. The retinoblastoma protein: A master regulator of cell cycle, differentiation and apoptosis. Eur J Biochem 246:581-601.
34. Hoemann CD, Beaulieu N, Girard L, Rebai N, Jolicoeur P. 2000. Twodistinct Notch1 mutant alleles are involved in the induction of T-cell leukemia in c-myc transgenic mice. Mol Cell Biol 20:3831-3842.
35. Izon DJ, Aster JC, He Y, Weng A, Karnell FG, Patriub V, Xu L, Bakkour S, Rodriguez C, Allman D, Pear WS. 2002. Deltex1 redirects lymphoid progenitors to the B cell lineage by antagonizing Notch1. Immunity 16:231-243.
36. Jang M-S, Zlobin A, Miele L. 2000. Notch signaling as a target in multimodality cancer therapy. Curr Opin Molec Therap 2:55-65.
37. Janicke RU, Walker PA, Lin XY, Porter AG. 1996. Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J 15:6969-6978.
38. Jeffries S, Capobianco AJ. 2000. Neoplastic transformation by notch requires nuclear localization [in process citation]. Mol Cell Biol 20: 3928-3941.
39. Jehn BM, Bielke W, Pear WS, Osborne BA. 1999. Protective effects of notch-1 on TCR-induced apoptosis. J Immunol 162:635-638.
40. Johnson GL, Lapadat R. 2002. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298:1911-1912.
41. Jundt F, Anagnostopoulos I, Forster R, Mathas S, Stein H, Dorken B. 2002. Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood 99:3398-3403.
42. Kadesch T. 2000. Notch signaling: A dance of proteins changing partners. Exp Cell Res 260:1-8.
43. Kao HY, Ordentlich P, Koyano-Nakagawa N, Tang Z, Downes M, Kintner CR, Evans RM, Kadesch T. 1998. A histone deacetylase corepressor complex regulates the Notch signal transduction pathway. Genes Dev 12:2269-2277.
44. Karanu FN, Murdoch B, Gallacher L, Wu DM, Koremoto M, Sakano S, Bhatia M. 2000. The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. J Exp Med 192: 1365-1372.
45. Karanu FN, Murdoch B, Miyabayashi T, Ohno M, Koremoto M, Gallacher L, Wu D, Itoh A, Sakano S, Bhatia M. 2001. Human homologues of Delta-1 and Delta-4 function as mitogenic regulators of primitive human hematopoietic cells. Blood 97:1960-1967.
46. Kardassis D, Papakosta P, Pardali K, Moustakas A. 1999. c-Jun transactivates the promoter of the human p21(WAF1/Cip1) gene by acting as a superactivator of the ubiquitous transcription factor Sp1. J Biol Chem 274:29572-29581.
47. Kiyokawa H, Richon VM, Venta-Perez G, Rifkind RA, Marks PA. 1993. Hexamethylenebisacetamide-induced erythroleukemia cell differentiation involves modulation of events required for cell cycle progression through G1. Proc Natl Acad Sci USA 90:6746-6750.
48. Leethanakul C, Patel V, Gillespie J, Pallente M, Ensley JF, Koontongkaew S, Liotta LA, Emmert-Buck M, Gutkind JS. 2000. Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene 19:3220-3224.
49. Leng L, Yu F, Dong L, Busquets X, Osada S, Richon VM, Marks PA, Rifkind RA. 1993. Differential modulation of protein kinase C isoforms in erythroleukemia during induced differentiation. Cancer Res 53:5554-5558.
50. Li L, Milner LA, Deng Y, Iwata M, Banta A, Graf L, Marcovina S, Friedman C, Trask BJ, Hood L, Torok-Storb B. 1998. The human homolog of rat Jagged1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch1. Immunity 8:43-55.
51. Lin A. 2003. Activation of the JNK signaling pathway: Breaking the brake on apoptosis. Bioessays 25:17-24.
52. Lowell S, Jones P, Le RI, Dunne J, Watt FM. 2000. Stimulation of human epidermal differentiation by delta-notch signalling at the boundaries of stem-cell dusters. Curr Biol 10:491-500.
53. Marks PA, Richon VM, Rifkind RA. 1996. Induced differentiation of cancer cells: Second generation potent hybrid polar compounds target cell cycle regulators. Eur J Cancer Prev 5(Suppl 2):75-77.
54. Matsuno K, Diederich RJ, Go MJ, Blaumueller CM, Artavanis-Tsakonas S. 1995. Deltex acts as a positive regulator of Notch signaling through interactions with the Notch ankyrin repeats. Development 121:2633-2644.
55. Matsuno K, Eastman D, Mitsiades T, Quinn AM, Carcanciu ML, Ordentlich P, Kadesch T, Artavanis-Tsakonas S. 1998. Human deltex is a conserved regulator of Notch signalling. Nat Genet 19: 74-78.
56. Matsuno K, Ito M, Hori K, Miyashita F, Suzuki S, Kishi N, Artavanis-Tsakonas S, Okano H. 2002. Involvement of a proline-rich motif and RING-H2 finger of Deltex in the regulation of Notch signaling. Development 129:1049-1059.
57. Michaeli J, Busquets X, Orlow I, Younes A, Colomer D, Marks PA, Rifkind RA, Kolesnick RN. 1992. A rise and fall in 1,2 diacylglycerol content signals hexamethylene bisacetamide-induced erythropoiesis. J Biol Chem 267:23463-23466.
58. Miele L, Osborne BA. 1999. Arbiter of differentiation and death: Notch signaling meets apoptosis. J Cell Physiol 181:393-409.
59. Miyamoto Y, Maitra A, Ghosh B, Zechner U, Argani P, Iacobuzio-Donahue CA, Sriuranpong V, Iso T, Meszoely IM, Wolfe MS, Hruban RH, Ball DW, Schmid RM, Leach SD. 2003. Notch mediates TGFalpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 3:565-576.
60. Morimura T, Goitsuka R, Zhang Y, Saito I, Reth M, Kitamura D. 2000. Cell cycle arrest and apoptosis induced by notch1 in B cells. J Biol Chem 275:36523-36531.
61. Nair P, Somasundaram K, Krishna S. 2003. Activated Notch-1 through PI3K-PKB/Akt inhibits p53 induced apoptosis and sustains transformation by HPV16 E6 and E7 oncogenes. J Virol 77:7106-7112.
62. Nead MA, Baglia LA, Antinore MJ, Ludlow JW, McCance DJ. 1998. Rb binds c-Jun and activates transcription. EMBO J 17:2342-2352.
63. Nickoloff BJ, Qin JZ, Chaturvedi V, Denning MF, Bonish B, Miele L. 2002. Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-kappaB and PPARgamma. Cell Death Differ 9:842-855.
64. Nickoloff BJ, Osborne B, Miele L. 2003. Notch signaling as a therapeutic target in cancer: A new approach to the development of cell fate modifiers. Oncogene 22:6598-6608.
65. Ohishi K, Varnum-Finney B, Flowers D, Anasetti C, Myerson D, Bernstein ID. 2000. Monocytes express high amounts of Notch and undergo cytokine specific apoptosis following interaction with the Notch ligand, Delta-1. Blood 95:2847-2854.
66. Ordentlich P, Lin A, Shen CP, Blaumueller C, Matsuno K, Artavanis-Tsakonas S, Kadesch T. 1998. Notch inhibition of E47 supports the existence of a novel signaling pathway. Mol Cell Biol 18:2230-2239.
67. Oswald F, Liptay S, Adler G, Schmid RM. 1998. NF-kappaB2 is a putative target gene of activated Notch-1 via RBP-Jkappa. Mol Cell Biol 18:2077-2088.
68. Patel R, Bartosch B, Blank JL. 1998. p21WAF1 is dynamically associated with JNK in human T-lymphocytes during cell cycle progression. J Cell Sci 111:2247-2255.
69. Pear WS, Aster JC, Scott ML, Hasserjian RP, Soffer B, Sklar J, Baltimore D. 1996. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med 183:2283-2291.
70. Rae FK, Stephenson SA, Nicol DL, Clements JA. 2000. Novel association of a diverse range of genes with renal cell carcinoma as identified by differential display. Int J Cancer 88:726-732.
71. Ramain P, Khechumian K, Seugnet L, Arbogast N, Ackermann C, Heitzler P. 2001. Novel Notch alleles reveal a Deltex-dependent pathway repressing neural fate. Curr Biol 11:1729-1738.
72. Rangarajan A, Syal R, Selvarajah S, Chakrabarti O, Sarin A, Krishna S. 2001a. Activated Notchl signaling cooperates with papillomavirus oncogenes in transformation and generates resistance to apoptosis on matrix withdrawal through PKB/Akt. Virology 286: 23-30.
73. Rangarajan A, Talora C, Okuyama R, Nicolas M, Mammucari C, Oh H, Aster JC, Krishna S, Metzger D, Chambon P, Miele L, Aguet M, Radtke F, Dotto GP. 2001b. Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J 20:3427-3436.
74. Robey E. 1999. Regulation of T cell fate by Notch. Annu Rev Immunol 17:283-295.
75. Ronchini C, Capobianco AJ. 2000. Notch(ic)-ER chimeras display hormone-dependent transformation, nuclear accumulation, phosphorylation and CBF1 activation. Oncogene 19:3914-3924.
76. Ronchini C, Capobianco AJ. 2001. Induction of cyclin D1 transcription and CDK2 activity by Notch(ic): Implication for cell cycle disruption in transformation by Notch(ic). Mol Cell Biol 21:5925-5934.
77. Schroeder T, Just U. 2000. mNotch1 signaling reduces proliferation of myeloid progenitor cells by altering cell-cycle kinetics. Exp Hematol 28:1206-1213.
78. Shan B, Lee WH. 1994. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol Cell Biol 14:8166-8173.
79. Shelly LL, Fuchs C, Miele L. 1999. Notch-1 prevents apoptosis in murine erythroleukemia cells and is necessary for differentiation induced by hybrid polar drugs. J Cell Biochem 73:164-175.
80. Srivastava RK, Sollott SJ, Khan L, Hansford R, Lakatta EG, Longo DL. 1999. Bcl-2 and Bcl-X(L) block thapsigargin-induced nitric oxide generation, c-Jun NH(2)-terminal kinase activity, and apoptosis. Mol Cell Biol 19:5659-5674.
81. Suzuki T, Aoki D, Susumu N, Udagawa Y, Nozawa S. 2000. Imbalanced expression of TAN-1 and human notch4 in endometrial cancers. Int J Oncol 17:1131-1139.
82. Tan X, Wang JY. 1998. The caspase-RB connection in cell death. Trends Cell Biol 8:116-120.
83. Tan-Pertel HT, Walker L, Browning D, Miyamoto A, Weinmaster G, Gasson JC. 2000. Notch signaling enhances survival and alters differentiation of 32D myeloblasts. J Immunol 165:4428-4436.
84. Tohda S, Nara N. 2001. Expression of Notch1 and Jagged1 proteins in acute myeloid leukemia cells. Leuk Lymphoma 42:467-472.
85. Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA, Davis RJ. 2000. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288:870-874.
86. Tsai S, Fero J, Bartelmez S. 2000. Mouse Jagged2 is differentially expressed in hematopoietic progenitors and endothelial cells and promotes the survival and proliferation of hematopoietic progenitors by direct cell-to-cell contact. Blood 96:950-957.
87. Tsukahara T, Kannagi M, Ohashi T, Kato H, Arai M, Nunez G, Iwanaga Y, Yamamoto N, Ohtani K, Nakamura M, Fujii M. 1999. Induction of Bcl-x(L) expression by human T-cell leukemia virus type 1 Tax through NF-kappaB in apoptosis-resistant T-cell transfectants with Tax. J Virol 73:7981-7987.
88. Walker L, Lynch M, Silverman S, Fraser J, Boulter J, Weinmaster G, Gasson JC. 1999. The Notch/Jagged pathway inhibits proliferation of human hematopoietic progenitors in vitro [in process citation]. Stem Cells 17:162-171.
89. Wang J, Shelly L, Miele L, Boykins R, Norcross MA, Guan E. 2001. Human Notch-1 inhibits NF-kappa B activity in the nucleus through a direct interaction involving a novel domain. J Immunol 167:289-295.
90. Weijzen S, Rizzo P, Braid M, Vaishnav R, Jonkheer SM, Zlobin A, Osborne BA, Gottipati S, Aster JC, Hahn WC, Rudolf M, Siziopikou K, Kast WM, Miele L. 2002a. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med 8:979-986.
91. Weijzen S, Velders MP, Elmishad AG, Bacon PE, Panella JR, Nickoloff BJ, Miele L, Kast WM. 2002b. The Notch ligand Jagged-1 is able to induce maturation of monocyte-derived human dendritic cells. J Immunol 169:4273-4278.
92. Weijzen S, Zlobin A, Braid M, Miele L, Kast WM. 2003. HPV16 E6 and E7 oncoproteins regulate Notch-1 expression and cooperate to induce transformation. J Cell Physiol 194:356-362.
93. Weng AP, Nam Y, Wolfe MS, Pear WS, Griffin JD, Blacklow SC, Aster JC. 2003. Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling. Mol Cell Biol 23: 655-664.
94. Wertz IE, Dixit VM. 2000. Characterization of calcium release-activated apoptosis of LNCaP prostate cancer cells. J Biol Chem 275:11470-11477.
95. Yamamoto N, Yamamoto S, Inagaki F, Kawaichi M, Fukamizu A, Kishi N, Matsuno K, Nakamura K, Weinmaster G, Okano H, Nakafuku M. 2001. Role of Deltex-1 as a transcriptional regulator downstream of the Notch receptor. J Biol Chem 276:45031-45040.
96. Yasutomo K, Doyle C, Fuchs C, Miele L, Germain RN. 2000. The duration of antigen receptor signalling determines CD4+ versus CD8+ T-cell lineage fate. Nature 404:506-510.
97. Yun TJ, Bevan MJ. 2003. Notch-regulated ankyrin-repeat protein inhibits notchl signaling: Multiple notch1 signaling pathways involved in T cell development. J Immunol 170:5834-5841.
98. Zagouras P, Stifani S, Blaumueller CM, Carcangiu ML, Artavanis-Tsakonas S. 1995. Alterations in Notch signaling in neoplastic lesions of the human cervix. Proc Natl Acad Sci USA 92:6414-6418.
99. Zanke BW, Boudreau K, Rubie E, Winnett E, Tibbles LA, Zon L, Kyriakis J, Liu FF, Woodgett JR. 1996. The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat. Curr Biol 6:606-613.
100. Zecchini V, Brennan K, Martinez-Arias A. 1999. An activity of notch regulates JNK signalling and affects dorsal closure in Drosophila. Curr Biol 9:460-469.
101. Zlobin A, Jang M-S, Miele L. 2000. Toward the rational design of cell fate modifiers: Notch signaling as a target for novel biopharmaceuticals. Curr Pharm Biotechnol 1:83-106.